FDA Approves Most Expensive Drug Ever, Priced At $3.5 Million-Per-Dose For Hemophilia

A $3.5 million (₹285,320,350.00 INR) one-time treatment for hemophilia has been approved by U.S. FDA on Tuesday. For adults with hemophilia B, a less common form of the genetic disorder which primarily affects men, the Food and Drug Administration has approved

FDA Approves Most Expensive Drug Ever, Priced At $3.5 Million-Per-Dose For Hemophilia
A $3.5 million (₹285,320,350.00 INR) one-time treatment for hemophilia has been approved by U.S. FDA on Tuesday. For adults with hemophilia B, a less common form of the genetic disorder which primarily affects men, the Food and Drug Administration has approved